Q4 2024 Earnings Call Transcript February 12, 2025 Operator: Good morning. My name is Jennifer and I will be your conference ...
Morgan Stanley analyst Terence Flynn lowered the firm’s price target on Biogen (BIIB) to $157 from $192 and keeps an Equal Weight rating on the ...
H.C. Wainwright lowered the firm’s price target on Biogen (BIIB) to $241 from $300 and keeps a Buy rating on the shares. The firm says that ...